tiprankstipranks
Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF
The Fly

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

Shuttle Pharmaceuticals (SHPH) announced a sponsored research agreement with the University of California, San Francisco, UCSF, to advance pre-clinical development of Shuttle Diagnostics’ ligand to the prostate-specific membrane antigen, PSMA, as a potential diagnostic and therapeutic, or theranostic, molecule. Theranostic molecules are suitable for diagnosis and therapy of cancers.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App